{
  "links": "https://www.ycombinator.com/companies/cb-therapeutics",
  "name": "CB Therapeutics",
  "headline": "Fermentation-derived natural products to solve health problems",
  "batch": "S18",
  "description": "CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.",
  "activity_status": "Active",
  "website": "http://www.cbthera.com",
  "founded_date": null,
  "team_size": 18.0,
  "location": "San Diego, CA",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:cellular-agriculture; industry:biotech",
  "founders": [
    {
      "name": "Jacob Vogan, Founder",
      "description": "I'm focused on improving the human condition by driving scientific research and products which treat mental health disorders, increase our healthspan, and promote longevity. I've worked at UC Davis and UCSF as a researcher. I completed my PhD and postdoc at UC Berkeley. I co-founded CB Therapeutics with the goal of developing a synthetic biology solution to deliver affordable CBD, which has now expanded into novel cannabinoids and tryptamines, like psilocybin, to treat myriad health issues.",
      "linkedin": "https://www.linkedin.com/in/jacob-vogan-885212143"
    },
    {
      "name": "Sher Butt, Founder/CEO",
      "description": null,
      "linkedin": "https://www.linkedin.com/in/sherbutt/"
    }
  ],
  "status": true,
  "markdown": "raw_markdown='[![](http://www.cbthera.com)](http://www.cbthera.com/<https:/www.cbthera.com>)\\n  * [Science](http://www.cbthera.com/<https:/www.cbthera.com/science-2/>)\\n  * [Team](http://www.cbthera.com/<https:/www.cbthera.com/team/>)\\n  * [Careers](http://www.cbthera.com/<https:/www.cbthera.com/careers/>)\\n  * [News](http://www.cbthera.com/<https:/www.cbthera.com/news-page/>)\\n  * [Contact](http://www.cbthera.com/<https:/www.cbthera.com/contact/>)\\n\\n\\n[![](https://www.cbthera.com/wp-content/uploads/brizy/imgs/cropped-CBThera-Logo-for-White-BG-no-box-500px-2-250x108x0x0x250x108x1673231041.png)](http://www.cbthera.com/<https:/www.cbthera.com>)\\n  * [Science](http://www.cbthera.com/<https:/www.cbthera.com/science-2/>)\\n  * [Team](http://www.cbthera.com/<https:/www.cbthera.com/team/>)\\n  * [Careers](http://www.cbthera.com/<https:/www.cbthera.com/careers/>)\\n  * [News](http://www.cbthera.com/<https:/www.cbthera.com/news-page/>)\\n  * [Contact](http://www.cbthera.com/<https:/www.cbthera.com/contact/>)\\n\\n\\nMental Health\\n[](http://www.cbthera.com/<mental-health>)\\nPHYSICAL HEALTH & WELLNESS\\n[](http://www.cbthera.com/<health-wellness>)\\nFood & nutrition\\n[](http://www.cbthera.com/<food-nutrition>)\\nPRECISION FERMENTATION\\n[](http://www.cbthera.com/<precision-fermentation>)\\n# Advancing Precision Synthetic Biology To Meet Humankind’s Greatest Challenges\\nCB Therapeutics, is a biotechnology company fully-focused on the design, development, and manufacture of compounds and processes to meet four distinct challenges that face humankind. Our top tier, senior team of scientists see the problems of [_Mental Health_](http://www.cbthera.com/<mental-health>) , [_Physical Health & Wellness_](http://www.cbthera.com/<health-wellness>), [_Food Scarcity & Nutrition_](http://www.cbthera.com/<food-nutrition>)and [_Precision Fermentation_](http://www.cbthera.com/<precision-fermentation>) as opportunities for our proprietary, proven, scalable, and sustainable, bio-manufacturing solutions to meet the needs of humankind. \\n[GET TO KNOW OUR SCIENCE](http://www.cbthera.com/<science-2>)\\n[](http://www.cbthera.com/<platform-2>)\\n[LEARN ABOUT OUR TEAM](http://www.cbthera.com/<team>)\\n[](http://www.cbthera.com/<team>)\\n# Breakthrough Science Powered by Yeast\\nWe have developed a cutting-edge proprietary yeast platform that enhances natural metabolic processes through precision fermentation to produce a variety of compounds, from small chemical analogs to bio-identical molecules that exactly match their counterparts in nature. The clear advantage for our efficient and sustainable production method is the rapid delivery of pure, consistent, and reliable molecules for our customers. \\n[GET TO KNOW OUR SCIENCE](http://www.cbthera.com/<science-2>)\\n## Robust Production Capabilities\\nCB Therapeutics is trailblazing the creation of new opportunities for precision synthetic biology by efficiently standardizing and scaling the production of the highest quality psychedelic therapeutics, cannabinoids, animal-free food ingredients, and many more high value molecules. We are already supplying, or in negotiations to supply, such diverse industries as neuroscience, clinical research, nutraceutical, cannabis, cosmetics, and the food and beverage markets.\\nPhytocannabinoids\\nCannabinoid analogs\\nTerpenes\\nTryptamines (psychedelics)\\nTryptamine analogs (psychedelics)\\nOther psychedelics\\nFood Tech\\nCellular Agriculture\\nNovel Food Additives\\n[SEE OUR PIPELINE ](http://www.cbthera.com/<pipeline>)\\n## We Are the Future for Precision Fermentation\\n**CB Therapeutics was purpose-built to create the new innovations and methods to sustainably manufacture tomorrow’s products to meet the challenge of a changing world. We are building a state-of-the-art precision fermentation bio-manufacturing facility adjacent to our labs, so we can begin to meet customer demand for our products in the commercial markets.**\\n![](http://www.cbthera.com)\\n## CB Therapeutics in the News\\nPeople are paying attention to us.\\n  * July 21, 2022\\n  * June 20, 2022\\n  * April 25, 2022\\n  * December 20, 2021\\n  * December 9, 2021\\n  * August 24, 2021\\n  * May 10, 2021\\n  * September 23, 2020\\n\\n\\nJuly 21, 2022\\n![](http://www.cbthera.com)\\n###### May 19, 2022\\n# To tackle sustainable food and active ingredient manufacturing, CB Therapeutics is developing eco-conscious solutions through precision fermentation\\nCARLSBAD, Calif., July 21, 2022 -- CB Therapeutics (the \"Company\"), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, has successfully developed various food tech prototypes using its next-gen synbio and precision fermentation platform. Now, the Company is looking for partnerships in the food technology and active ingredient spaces that align with its value propositions.\\n[READ MORE](http://www.cbthera.com/<https:/www.cbthera.com/2022/07/21/to-tackle-sustainable-food-and-active-ingredient-manufacturing-cb-therapeutics-is-developing-eco-conscious-solutions-through-precision-fermentation/>)\\nJune 20, 2022\\n![](http://www.cbthera.com)\\n###### May 19, 2022\\n# CB Therapeutics’ Business Development Lead, Tiffany Hurd, is Further Bridging the Gap Between Pharma and Psychedelics\\nCARLSBAD, Calif., June 20, 2022 (GLOBE NEWSWIRE) — CB Therapeutics (the \"Company\"), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, welcomes a new member of the team who is focused on growth and sustainability.\\n[READ MORE](http://www.cbthera.com/<https:/www.globenewswire.com/en/news-release/2022/05/19/2447249/0/en/CB-Therapeutics-granted-a-new-patent-that-will-help-further-provide-eco-conscious-avenues-for-psychedelic-research.html>)\\nApril 25, 2022\\n![](http://www.cbthera.com)\\n###### April 25, 2022\\n# CB Therapeutics rapidly expands cellular agriculture capabilities at new facility\\nCARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- CB Therapeutics (the “Company”), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, is celebrating a move to an expanded laboratory, which will serve to \\nincrease its research compound production footprint.\\n[READ MORE](http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2022/04/25/2428142/0/en/CB-Therapeutics-rapidly-expands-cellular-agriculture-capabilities-at-new-facility.html>)\\nDecember 20, 2021\\n![](http://www.cbthera.com)\\n###### December 20, 2021\\n# Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities\\nSAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board.\\n[READ MORE](http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2021/12/20/2355218/0/en/Two-esteemed-doctors-join-CB-Therapeutics-in-its-exploration-of-innovative-approaches-to-the-production-of-novel-psychedelics-and-cannabinoids-so-researchers-can-address-the-unmet-.html>)\\nDecember 9, 2021\\n![](http://www.cbthera.com)\\n###### December 9, 2021\\n# CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis\\nSAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase healthspan, believes their partnership with atai Life Sciences will help to meet the growing unmet needs of patients with mental health conditions.\\n[READ MORE](http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2021/12/09/2349577/0/en/CB-Therapeutics-and-atai-Life-Sciences-launch-TryptageniX-to-sustainably-supply-and-develop-clinically-relevant-compounds-to-tackle-the-growing-mental-health-crisis.html>)\\nAugust 24, 2021\\n![](http://www.cbthera.com)\\n###### August 24, 2021\\n### **CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT and Related Tryptamine-based Compounds**\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is happy to announce that it has been awarded two more patents for the novel methods of production of high value molecules using cutting-edge biosynthesis technologies. These patents (11,041,002B1 and 10,988,785B1) cover inventions on cellular agriculture breakthroughs for producing cannabinoids and precursors to various other compounds...\\n[READ MORE](http://www.cbthera.com/<https:/www.businesswire.com/news/home/20210824005126/en/CB-Therapeutics-Expands-Biomanufacturing-IP-Portfolio>)\\nMay 10, 2021\\n![](http://www.cbthera.com)\\n###### May 10, 2021\\n### CB Therapeutics Closes on Oversubscribed Series A\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., the leading synthetic biology company focused on the development and biosynthetic production of existing and novel tryptamines and cannabinoids, is pleased to announce that it has closed an oversubscribed Series A funding round, filled entirely by re.Mind Capital, a fund launched by the psychedelics kingmaker, Christian Angermayer within Apeiron, his family office…\\n[READ MORE](http://www.cbthera.com/<https:/www.businesswire.com/news/home/20210510005112/en/CB-Therapeutics-Closes-on-Oversubscribed-Series-A>)\\nSeptember 23, 2020\\n![](http://www.cbthera.com)\\n###### September 23, 2020\\n### CB Therapeutics Achieves Major Breakthroughs in Downstream Processing and Purification, Paving the Way for Low-cost Cannabinoids, Tryptamines, and Their Analogs\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., has successfully refined its in-house downstream processing, allowing for 99.6% pure CBC. a rare cannabinoid molecule found in trace quantities in cannabis and hemp. Using these patent-pending techniques, CB Therapeutics is able to drive down the cost of purification in parallel with increasing the purity to over 99%, considered a major breakthrough for any type of purification process…\\n[READ MORE](http://www.cbthera.com/<https:/www.businesswire.com/news/home/20200923005135/en/CB-Therapeutics-Achieves-Major-Breakthroughs-in-Downstream-Processing-and-Purification-Paving-the-Way-for-Low-cost-Cannabinoids-Tryptamines-and-Their-Analogs>)\\n[NEWS ARCHIVE](http://www.cbthera.com/<news-page>)\\n[![](http://www.cbthera.com)](http://www.cbthera.com/<https:/www.cbthera.com>)\\n###### 2463 Impala Drive\\nCarlsbad, CA, USA 92010\\nCall us now at: [+1 (833) 322-8437](http://www.cbthera.com/<tel:+18333228437>)\\n[](http://www.cbthera.com/<https:/facebook.com/CBThera>)\\n[](http://www.cbthera.com/<https:/www.linkedin.com/company/cb-therapeutics>)\\n[](http://www.cbthera.com/<https:/twitter.com/CBTherapeutics>)\\n[](http://www.cbthera.com/<https:/instagram.com/cb_thera>)\\n© 2023 CB Therapeutics | All Rights Reserved\\n## Would you like to learn more?\\n**We’ll respond as soon as possible from our laboratory and headquarters in sunny Carlsbad, California.**\\nCONNECT WITH US\\n[Privacy Policy](http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601> \"Privacy Policy \") | [Cookie Policy](http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601/cookie-policy> \"Cookie Policy \")\\n×\\n## Notice\\nWe and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the [cookie policy](http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601/cookie-policy?an=no&s_ck=false&newmarkup=yes>). \\nUse the “Accept” button or close this notice to consent. \\nPress again to continue 0/1\\nLearn more\\nAccept\\n' markdown_with_citations='![⟨1⟩](http://www.cbthera.com/<https:/www.cbthera.com>)\\n  * Science⟨2⟩\\n  * Team⟨3⟩\\n  * Careers⟨4⟩\\n  * News⟨5⟩\\n  * Contact⟨6⟩\\n\\n\\n![⟨7⟩](http://www.cbthera.com/<https:/www.cbthera.com>)\\n  * Science⟨2⟩\\n  * Team⟨3⟩\\n  * Careers⟨4⟩\\n  * News⟨5⟩\\n  * Contact⟨6⟩\\n\\n\\nMental Health\\n[](http://www.cbthera.com/<mental-health>)\\nPHYSICAL HEALTH & WELLNESS\\n[](http://www.cbthera.com/<health-wellness>)\\nFood & nutrition\\n[](http://www.cbthera.com/<food-nutrition>)\\nPRECISION FERMENTATION\\n[](http://www.cbthera.com/<precision-fermentation>)\\n# Advancing Precision Synthetic Biology To Meet Humankind’s Greatest Challenges\\nCB Therapeutics, is a biotechnology company fully-focused on the design, development, and manufacture of compounds and processes to meet four distinct challenges that face humankind. Our top tier, senior team of scientists see the problems of _Mental Health_⟨8⟩ , _Physical Health & Wellness_⟨9⟩, _Food Scarcity & Nutrition_⟨10⟩and _Precision Fermentation_⟨11⟩ as opportunities for our proprietary, proven, scalable, and sustainable, bio-manufacturing solutions to meet the needs of humankind. \\nGET TO KNOW OUR SCIENCE⟨12⟩\\n[](http://www.cbthera.com/<platform-2>)\\nLEARN ABOUT OUR TEAM⟨13⟩\\n[](http://www.cbthera.com/<team>)\\n# Breakthrough Science Powered by Yeast\\nWe have developed a cutting-edge proprietary yeast platform that enhances natural metabolic processes through precision fermentation to produce a variety of compounds, from small chemical analogs to bio-identical molecules that exactly match their counterparts in nature. The clear advantage for our efficient and sustainable production method is the rapid delivery of pure, consistent, and reliable molecules for our customers. \\nGET TO KNOW OUR SCIENCE⟨12⟩\\n## Robust Production Capabilities\\nCB Therapeutics is trailblazing the creation of new opportunities for precision synthetic biology by efficiently standardizing and scaling the production of the highest quality psychedelic therapeutics, cannabinoids, animal-free food ingredients, and many more high value molecules. We are already supplying, or in negotiations to supply, such diverse industries as neuroscience, clinical research, nutraceutical, cannabis, cosmetics, and the food and beverage markets.\\nPhytocannabinoids\\nCannabinoid analogs\\nTerpenes\\nTryptamines (psychedelics)\\nTryptamine analogs (psychedelics)\\nOther psychedelics\\nFood Tech\\nCellular Agriculture\\nNovel Food Additives\\nSEE OUR PIPELINE ⟨14⟩\\n## We Are the Future for Precision Fermentation\\n**CB Therapeutics was purpose-built to create the new innovations and methods to sustainably manufacture tomorrow’s products to meet the challenge of a changing world. We are building a state-of-the-art precision fermentation bio-manufacturing facility adjacent to our labs, so we can begin to meet customer demand for our products in the commercial markets.**\\n![](http://www.cbthera.com)\\n## CB Therapeutics in the News\\nPeople are paying attention to us.\\n  * July 21, 2022\\n  * June 20, 2022\\n  * April 25, 2022\\n  * December 20, 2021\\n  * December 9, 2021\\n  * August 24, 2021\\n  * May 10, 2021\\n  * September 23, 2020\\n\\n\\nJuly 21, 2022\\n![](http://www.cbthera.com)\\n###### May 19, 2022\\n# To tackle sustainable food and active ingredient manufacturing, CB Therapeutics is developing eco-conscious solutions through precision fermentation\\nCARLSBAD, Calif., July 21, 2022 -- CB Therapeutics (the \"Company\"), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, has successfully developed various food tech prototypes using its next-gen synbio and precision fermentation platform. Now, the Company is looking for partnerships in the food technology and active ingredient spaces that align with its value propositions.\\nREAD MORE⟨15⟩\\nJune 20, 2022\\n![](http://www.cbthera.com)\\n###### May 19, 2022\\n# CB Therapeutics’ Business Development Lead, Tiffany Hurd, is Further Bridging the Gap Between Pharma and Psychedelics\\nCARLSBAD, Calif., June 20, 2022 (GLOBE NEWSWIRE) — CB Therapeutics (the \"Company\"), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, welcomes a new member of the team who is focused on growth and sustainability.\\nREAD MORE⟨16⟩\\nApril 25, 2022\\n![](http://www.cbthera.com)\\n###### April 25, 2022\\n# CB Therapeutics rapidly expands cellular agriculture capabilities at new facility\\nCARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- CB Therapeutics (the “Company”), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, is celebrating a move to an expanded laboratory, which will serve to \\nincrease its research compound production footprint.\\nREAD MORE⟨17⟩\\nDecember 20, 2021\\n![](http://www.cbthera.com)\\n###### December 20, 2021\\n# Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities\\nSAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board.\\nREAD MORE⟨18⟩\\nDecember 9, 2021\\n![](http://www.cbthera.com)\\n###### December 9, 2021\\n# CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis\\nSAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase healthspan, believes their partnership with atai Life Sciences will help to meet the growing unmet needs of patients with mental health conditions.\\nREAD MORE⟨19⟩\\nAugust 24, 2021\\n![](http://www.cbthera.com)\\n###### August 24, 2021\\n### **CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT and Related Tryptamine-based Compounds**\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is happy to announce that it has been awarded two more patents for the novel methods of production of high value molecules using cutting-edge biosynthesis technologies. These patents (11,041,002B1 and 10,988,785B1) cover inventions on cellular agriculture breakthroughs for producing cannabinoids and precursors to various other compounds...\\nREAD MORE⟨20⟩\\nMay 10, 2021\\n![](http://www.cbthera.com)\\n###### May 10, 2021\\n### CB Therapeutics Closes on Oversubscribed Series A\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., the leading synthetic biology company focused on the development and biosynthetic production of existing and novel tryptamines and cannabinoids, is pleased to announce that it has closed an oversubscribed Series A funding round, filled entirely by re.Mind Capital, a fund launched by the psychedelics kingmaker, Christian Angermayer within Apeiron, his family office…\\nREAD MORE⟨21⟩\\nSeptember 23, 2020\\n![](http://www.cbthera.com)\\n###### September 23, 2020\\n### CB Therapeutics Achieves Major Breakthroughs in Downstream Processing and Purification, Paving the Way for Low-cost Cannabinoids, Tryptamines, and Their Analogs\\nSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., has successfully refined its in-house downstream processing, allowing for 99.6% pure CBC. a rare cannabinoid molecule found in trace quantities in cannabis and hemp. Using these patent-pending techniques, CB Therapeutics is able to drive down the cost of purification in parallel with increasing the purity to over 99%, considered a major breakthrough for any type of purification process…\\nREAD MORE⟨22⟩\\nNEWS ARCHIVE⟨23⟩\\n![⟨1⟩](http://www.cbthera.com/<https:/www.cbthera.com>)\\n###### 2463 Impala Drive\\nCarlsbad, CA, USA 92010\\nCall us now at: +1 (833) 322-8437⟨24⟩\\n[](http://www.cbthera.com/<https:/facebook.com/CBThera>)\\n[](http://www.cbthera.com/<https:/www.linkedin.com/company/cb-therapeutics>)\\n[](http://www.cbthera.com/<https:/twitter.com/CBTherapeutics>)\\n[](http://www.cbthera.com/<https:/instagram.com/cb_thera>)\\n© 2023 CB Therapeutics | All Rights Reserved\\n## Would you like to learn more?\\n**We’ll respond as soon as possible from our laboratory and headquarters in sunny Carlsbad, California.**\\nCONNECT WITH US\\nPrivacy Policy⟨25⟩ | Cookie Policy⟨26⟩\\n×\\n## Notice\\nWe and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the cookie policy⟨27⟩. \\nUse the “Accept” button or close this notice to consent. \\nPress again to continue 0/1\\nLearn more\\nAccept\\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ http://www.cbthera.com: ![\\n⟨2⟩ http://www.cbthera.com/<https:/www.cbthera.com/science-2/>: Science\\n⟨3⟩ http://www.cbthera.com/<https:/www.cbthera.com/team/>: Team\\n⟨4⟩ http://www.cbthera.com/<https:/www.cbthera.com/careers/>: Careers\\n⟨5⟩ http://www.cbthera.com/<https:/www.cbthera.com/news-page/>: News\\n⟨6⟩ http://www.cbthera.com/<https:/www.cbthera.com/contact/>: Contact\\n⟨7⟩ https://www.cbthera.com/wp-content/uploads/brizy/imgs/cropped-CBThera-Logo-for-White-BG-no-box-500px-2-250x108x0x0x250x108x1673231041.png: ![\\n⟨8⟩ http://www.cbthera.com/<mental-health>: _Mental Health_\\n⟨9⟩ http://www.cbthera.com/<health-wellness>: _Physical Health & Wellness_\\n⟨10⟩ http://www.cbthera.com/<food-nutrition>: _Food Scarcity & Nutrition_\\n⟨11⟩ http://www.cbthera.com/<precision-fermentation>: _Precision Fermentation_\\n⟨12⟩ http://www.cbthera.com/<science-2>: GET TO KNOW OUR SCIENCE\\n⟨13⟩ http://www.cbthera.com/<team>: LEARN ABOUT OUR TEAM\\n⟨14⟩ http://www.cbthera.com/<pipeline>: SEE OUR PIPELINE \\n⟨15⟩ http://www.cbthera.com/<https:/www.cbthera.com/2022/07/21/to-tackle-sustainable-food-and-active-ingredient-manufacturing-cb-therapeutics-is-developing-eco-conscious-solutions-through-precision-fermentation/>: READ MORE\\n⟨16⟩ http://www.cbthera.com/<https:/www.globenewswire.com/en/news-release/2022/05/19/2447249/0/en/CB-Therapeutics-granted-a-new-patent-that-will-help-further-provide-eco-conscious-avenues-for-psychedelic-research.html>: READ MORE\\n⟨17⟩ http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2022/04/25/2428142/0/en/CB-Therapeutics-rapidly-expands-cellular-agriculture-capabilities-at-new-facility.html>: READ MORE\\n⟨18⟩ http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2021/12/20/2355218/0/en/Two-esteemed-doctors-join-CB-Therapeutics-in-its-exploration-of-innovative-approaches-to-the-production-of-novel-psychedelics-and-cannabinoids-so-researchers-can-address-the-unmet-.html>: READ MORE\\n⟨19⟩ http://www.cbthera.com/<https:/www.globenewswire.com/news-release/2021/12/09/2349577/0/en/CB-Therapeutics-and-atai-Life-Sciences-launch-TryptageniX-to-sustainably-supply-and-develop-clinically-relevant-compounds-to-tackle-the-growing-mental-health-crisis.html>: READ MORE\\n⟨20⟩ http://www.cbthera.com/<https:/www.businesswire.com/news/home/20210824005126/en/CB-Therapeutics-Expands-Biomanufacturing-IP-Portfolio>: READ MORE\\n⟨21⟩ http://www.cbthera.com/<https:/www.businesswire.com/news/home/20210510005112/en/CB-Therapeutics-Closes-on-Oversubscribed-Series-A>: READ MORE\\n⟨22⟩ http://www.cbthera.com/<https:/www.businesswire.com/news/home/20200923005135/en/CB-Therapeutics-Achieves-Major-Breakthroughs-in-Downstream-Processing-and-Purification-Paving-the-Way-for-Low-cost-Cannabinoids-Tryptamines-and-Their-Analogs>: READ MORE\\n⟨23⟩ http://www.cbthera.com/<news-page>: NEWS ARCHIVE\\n⟨24⟩ http://www.cbthera.com/<tel:+18333228437>: +1 (833) 322-8437\\n⟨25⟩ http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601>: Privacy Policy  - Privacy Policy\\n⟨26⟩ http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601/cookie-policy>: Cookie Policy  - Cookie Policy\\n⟨27⟩ http://www.cbthera.com/<https:/www.iubenda.com/privacy-policy/32325601/cookie-policy?an=no&s_ck=false&newmarkup=yes>: cookie policy\\n' fit_markdown='' fit_html=''",
  "generated_description": "**CB Therapeutics: Pioneering Health Solutions through Synthetic Biology**\n\nCB Therapeutics is a synthetic biology company on a mission to harness the power of fermentation-derived natural products to tackle pressing health challenges. Founded as part of Y Combinator's Batch S18, this innovative startup is primarily focused on developing cannabinoid and tryptamine therapeutics. Located in San Diego, California, the company has a tight-knit team of 18 individuals dedicated to addressing a range of mental health issues including depression, PTSD, opioid addiction, alcoholism, and chronic pain.\n\n### What They Do\n\nCB Therapeutics aims to advance the field of synthetic biology by leveraging precision fermentation techniques. Their proprietary yeast platform enhances natural metabolic processes to produce a variety of compounds, including cannabinoids and psychedelics, with high purity and consistency. This efficient and scalable production method promises sustainable solutions for several industries—including neuroscience, nutraceuticals, cosmetics, food, and beverage markets.\n\nHere are the primary focus areas:\n\n1. **Mental Health**: Developing treatments for disorders like depression and PTSD.\n2. **Physical Health & Wellness**: Creating therapeutic solutions for improved well-being.\n3. **Food Scarcity & Nutrition**: Innovating food tech through cellular agriculture.\n4. **Precision Fermentation**: Utilizing their cutting-edge bio-manufacturing capabilities.\n\n### Innovative Practices\n\nCB Therapeutics is ahead of the curve, building state-of-the-art facilities to expand their manufacturing capabilities. They are already supplying or negotiating partnerships across diverse sectors, underlining their commitment to meeting market demand with ethical, environmentally friendly products. \n\nThrough careful cultivation of their bio-manufacturing processes, they're not just contributing to modern health solutions; they're shaping the future of how we understand and produce health-related products. \n\nFor further inquiries or to learn more about their initiatives, check out their website [CB Therapeutics](http://www.cbthera.com).\n\n### Summary\n\nIn short, CB Therapeutics isn't just another biotech company—it's on a quest to create a sustainable, healthier future through innovative science. By focusing on natural fermentation methods and addressing significant health issues, they hold potential not just for profits, but for positive global impact. Keep an eye on them; they could be at the forefront of the health revolution in the years to come."
}